Neoplasia/BPH

	Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer. J Immunother Cancer Li C, Madan RA, Lee MJ, Lee S, Sato N, Rastogi S, Shrestha R, Aragon-Ching JB, Goswami M, Donahue RN, Cordes LM, Baj A, Seo CCY, Terrigino NT, Bright JR, Hennigan ST, King IM, Trostel SY, Fenimore JM, Liu Y, Calzone KA, Schlom J, Gulley JL, Dahut WL, Figg WD, Sowalsky AG, Lee JM, Karzai F. PMID: 41881502 [PubMed - indexed for MEDLINE]
	Evaluation of handgrip strength and prostate cancer risk using propensity score matching in 64,371 European men. Maturitas Qaisar R, Hussain MA, Karim A, Ahmad F, Naheed S, Saeed K, Alkahtani SA. PMID: 41880876 [PubMed - as supplied by publisher]
	UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial. J Urol Prasad SM, Shishkov D, Mihaylov NV, Genov P, Terzi V, Kates M, Huang WC, Louie MJ, Burger B, Meads A, Schoenberg M. PMID: 41880645 [PubMed - as supplied by publisher]
	Transdermal Estradiol Patches in Locally Advanced Prostate Cancer. N Engl J Med Langley RE, Gilbert DC, Mangar S, Rosen S, Bourmaki E, Rush HL, Kananga Sundaram S, Alhasso A, Kockelbergh R, Abdel-Aty H, Amos CL, Brown L, Brown S, Carvalho C, Chan K, Collins G, Cross W, Deighan J, Dixit S, Duong T, Dyer J, Gale J, Gillessen S, Griffiths A, Laniado M, Lydon A, McPhail N, MacNair A, Madaan S, Marshall J, Matheson D, Millman R, Mohamed W, Murphy L, Narahari K, Parker C, Panades M, Pope A, Raval A, Robinson A, Russell M, Scrase C, Sydes M, Turo R, Venkitaraman R, Wade S, Kynaston H, Attard G, James ND, Clarke N, Parmar MK, Nankivell M, STAMPEDE-1 and PATCH Investigators. PMID: 41880608 [PubMed - as supplied by publisher]
	Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 Study. Clin Cancer Res Antonarakis ES, Cao Q, Catharine V, Carneiro BA, De Souza AL, VanderWeele DJ, Singh P, Bryce AH, Kelly WK, Jha GG, Lewis B, Barata PC, Sartor AO, Stadler WM, Proudfoot JA, Davicioni E, Dhawan M, Morgans AK, Ryan CJ. PMID: 41880596 [PubMed - as supplied by publisher]
	Use of a Delphi process to formulate a pragmatic framework for care planning in older adults with advanced bladder cancer. Support Care Cancer Kessler ER, Hoover K, Coats H, Fischer SM. PMID: 41880032 [PubMed - indexed for MEDLINE]
	[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]. Urologie Niegisch G, Gakis G, Ohlmann CH, Knüchel-Clarke R, Beyersdorff D, Rick O, Golka K, Hegemann M, Goebell PJ, Maisch P, Gschwend J. PMID: 41879995 [PubMed - as supplied by publisher]
	Correction to: Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging Donswijk ML, Ettema RH, Wondergem M, Cheung Z, van der Poel HG, Oprea-Lager DE, Vis AN. PMID: 41879990 [PubMed - as supplied by publisher]
	Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results. Scand J Urol Ventimiglia E, Gedeborg R, Westerberg M, Zaurito P, Jäderling F, Stattin P, Garmo H. PMID: 41879676 [PubMed - indexed for MEDLINE]
	Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma. Int J Urol Ishihara H, Katsurayama N, Nemoto Y, Mizoguchi S, Nakayama T, Fukuda H, Shimmura H, Hashimoto Y, Yoshida K, Iizuka J, Kondo T, Takagi T. PMID: 41879266 [PubMed - indexed for MEDLINE]
	Real-world precision medicine data in metastatic prostate cancer - a retrospective cohort study. Front Oncol Paracha A, Tran D, Noyelle M, Kapilian J, Siddiqui Z, Choppa A, Corsi A, Stone J, Zhu XH. PMID: 41878526 [PubMed]
	Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients. Front Immunol Tornesello ML, Piccirillo MC, Tambaro R, Simeon V. PMID: 41878440 [PubMed - indexed for MEDLINE]
	Multicentre Evaluation of an AI-Assisted Urine Test for Clinically Significant Prostate Cancer in Men Undergoing Initial Biopsy. J Extracell Vesicles Jiang S, Yang C, Huang Z, Guo Z, Lu F, Nian X, Chen Z, Luo P, Jiang J, Gao X, Li M, Liu F. PMID: 41877634 [PubMed - indexed for MEDLINE]
	Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts. Eur J Cancer Prev Ben Souilah F, Tourigny R, Drouin-Chartier JP, Diorio C, Fradet V. PMID: 41877536 [PubMed - as supplied by publisher]
	Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms. Cell Commun Signal Wang J, Wu R, Tuo Z, Okoli UA, Wang Z, Chaipanichkul P, Koh SB, Li D, Lyu Z, Umber C, Zhang Q, Feng D. PMID: 41877195 [PubMed - as supplied by publisher]
	Stage-specific associations of HER2 overexpression with clinical and pathological features in bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol Guo C, Wei J, Wang Y, Zhang L, Wu X, Sheng X. PMID: 41876828 [PubMed - as supplied by publisher]
	Evaluating the safety profile of Î±-1 blockers, 5Î±-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS). Aging Male Zhao Z, Wu C, Xiong Y, Wang W, Qin F, Yuan J. PMID: 41876378 [PubMed - indexed for MEDLINE]
	Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance. Cancer Med Yan X, Tang X, Guo L, He Z, Liu S, Wu S, Li Z, Liu TZ, Zheng H, Zhang W, Li S. PMID: 41876361 [PubMed - indexed for MEDLINE]
	Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing. Radiother Oncol Fredman E, Attrash M, Yosefof E, Moore A, Tschernichovsky R, Bragilovski D, Weinstock-Sabbah M, Kindler J, Azuz RD, Radus R, Icht O, Golan S, Shochet T, Limon D. PMID: 41876028 [PubMed - as supplied by publisher]
	[Early Detection of Prostate Cancer: Current Real-World Data from the VERSUS Study by d-uo]. Aktuelle Urol Doehn C, König F, Johannsen M, Eichenauer R, Schönfelder R, Doehn ML, Schröder J, Hempel E, Klier J. PMID: 41875916 [PubMed - as supplied by publisher]

Articles 1 - 20 / 186566

Page 1 of 9329



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy